Year |
Citation |
Score |
2025 |
Godinez-Macias KP, Chen D, Wallis JL, Siegel MG, Adam A, Bopp S, Carolino K, Coulson LB, Durst G, Thathy V, Esherick L, Farringer MA, Flannery EL, Forte B, Liu T, et al. Revisiting the druggable genome using predicted structures and data mining. Npj Drug Discovery. 2: 3. PMID 40066064 DOI: 10.1038/s44386-025-00006-5 |
0.618 |
|
2024 |
Godinez-Macias KP, Chen D, Wallis JL, Siegel MG, Adam A, Bopp S, Carolino K, Coulson LB, Durst G, Thathy V, Esherick L, Farringer MA, Flannery EL, Forte B, Liu T, et al. Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining. Research Square. PMID 39649165 DOI: 10.21203/rs.3.rs-5412515/v1 |
0.753 |
|
2023 |
Ullah I, Farringer MA, Burkhard AY, Hathaway E, Willett BC, Khushu M, Shin SH, Sharma AI, Shao KL, Martin MC, Dvorin JD, Hartl DL, Volkman SK, Bopp S, Absalon S, et al. Artemisinin resistance mutations in impede hemoglobin uptake. Biorxiv : the Preprint Server For Biology. PMID 38187525 DOI: 10.1101/2023.12.22.572193 |
0.44 |
|
2023 |
Bopp S, Pasaje CFA, Summers RL, Magistrado-Coxen P, Schindler KA, Corpas-Lopez V, Yeo T, Mok S, Dey S, Smick S, Nasamu AS, Demas AR, Milne R, Wiedemar N, Corey V, et al. Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation. Nature Communications. 14: 1455. PMID 36927839 DOI: 10.1038/s41467-023-36921-2 |
0.807 |
|
2022 |
Paton DG, Probst AS, Ma E, Adams KL, Shaw WR, Singh N, Bopp S, Volkman SK, Hien DFS, Paré PSL, Yerbanga RS, Diabaté A, Dabiré RK, Lefèvre T, Wirth DF, et al. Using an antimalarial in mosquitoes overcomes Anopheles and Plasmodium resistance to malaria control strategies. Plos Pathogens. 18: e1010609. PMID 35687594 DOI: 10.1371/journal.ppat.1010609 |
0.502 |
|
2020 |
Sharma AI, Shin SH, Bopp S, Volkman SK, Hartl DL, Wirth DF. Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum. Plos Genetics. 16: e1009266. PMID 33370279 DOI: 10.1371/journal.pgen.1009266 |
0.418 |
|
2019 |
Meibalan E, Barry A, Gibbins MP, Awandu S, Meerstein-Kessel L, Achcar F, Bopp S, Moxon C, Diarra A, Debe S, Ouédraogo N, Barry-Some I, Badoum E, Fagnima T, Lanke K, et al. P. falciparum gametocyte density and infectivity in peripheral blood and skin tissue of naturally infected parasite carriers in Burkina Faso. The Journal of Infectious Diseases. PMID 31875909 DOI: 10.1093/Infdis/Jiz680 |
0.326 |
|
2019 |
Chen AJ, Huang KC, Bopp S, Summers R, Dong P, Huang Y, Zong C, Wirth D, Cheng JX. Quantitative imaging of intraerythrocytic hemozoin by transient absorption microscopy. Journal of Biomedical Optics. 25: 1-11. PMID 31849205 DOI: 10.1117/1.Jbo.25.1.014507 |
0.429 |
|
2019 |
Fagbami L, Deik AA, Herman JD, Singh K, Santos SA, Bopp S, Lukens AK, Clish CB, Wirth DF, Mazitschek R. The adaptive proline response in P. falciparum is independent of PfeIK1 and eIF2α signaling. Acs Infectious Diseases. PMID 30773881 DOI: 10.1021/Acsinfecdis.8B00363 |
0.352 |
|
2018 |
Demas AR, Sharma AI, Wong W, Early AM, Redmond S, Bopp S, Neafsey DE, Volkman SK, Hartl DL, Wirth DF. Mutations in actin-binding protein coronin confer reduced artemisinin susceptibility. Proceedings of the National Academy of Sciences of the United States of America. PMID 30420498 DOI: 10.1073/Pnas.1812317115 |
0.568 |
|
2018 |
Redmond SN, MacInnis BM, Bopp S, Bei AK, Ndiaye D, Hartl DL, Wirth DF, Volkman SK, Neafsey DE. De Novo Mutations Resolve Disease Transmission Pathways in Clonal Malaria. Molecular Biology and Evolution. PMID 29722884 DOI: 10.1093/Molbev/Msy059 |
0.485 |
|
2018 |
Bopp S, Magistrado P, Wong W, Schaffner SF, Mukherjee A, Lim P, Dhorda M, Amaratunga C, Woodrow CJ, Ashley EA, White NJ, Dondorp AM, Fairhurst RM, Ariey F, Menard D, et al. Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum. Nature Communications. 9: 1769. PMID 29720620 DOI: 10.1038/S41467-018-04104-Z |
0.461 |
|
2018 |
Cowell AN, Istvan ES, Lukens AK, Gomez-Lorenzo MG, Vanaerschot M, Sakata-Kato T, Flannery EL, Magistrado P, Owen E, Abraham M, LaMonte G, Painter HJ, Williams RM, Franco V, Linares M, ... ... Bopp S, et al. Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics. Science (New York, N.Y.). 359: 191-199. PMID 29326268 DOI: 10.1126/Science.Aan4472 |
0.722 |
|
2017 |
Brancucci NMB, Gerdt JP, Wang C, De Niz M, Philip N, Adapa SR, Zhang M, Hitz E, Niederwieser I, Boltryk SD, Laffitte MC, Clark MA, Grüring C, Ravel D, Blancke Soares A, ... ... Bopp S, et al. Lysophosphatidylcholine Regulates Sexual Stage Differentiation in the Human Malaria Parasite Plasmodium falciparum. Cell. PMID 29129376 DOI: 10.1016/J.Cell.2017.10.020 |
0.383 |
|
2017 |
Mukherjee A, Bopp S, Magistrado P, Wong W, Daniels R, Demas A, Schaffner S, Amaratunga C, Lim P, Dhorda M, Miotto O, Woodrow C, Ashley EA, Dondorp AM, White NJ, et al. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia. Malaria Journal. 16: 195. PMID 28494763 DOI: 10.1186/S12936-017-1845-5 |
0.539 |
|
2016 |
Ng CL, Siciliano G, Lee MC, de Almeida MJ, Corey VC, Bopp SE, Bertuccini L, Wittlin S, Kasdin RG, Le Bihan A, Clozel M, Winzeler EA, Alano P, Fidock DA. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs. Molecular Microbiology. PMID 27073104 DOI: 10.1111/Mmi.13397 |
0.812 |
|
2015 |
Herman JD, Pepper LR, Cortese JF, Estiu G, Galinsky K, Zuzarte-Luis V, Derbyshire ER, Ribacke U, Lukens AK, Santos SA, Patel V, Clish CB, Sullivan WJ, Zhou H, Bopp SE, et al. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs. Science Translational Medicine. 7: 288ra77. PMID 25995223 DOI: 10.1126/Scitranslmed.Aaa3575 |
0.512 |
|
2014 |
Manary MJ, Singhakul SS, Flannery EL, Bopp SE, Corey VC, Bright AT, McNamara CW, Walker JR, Winzeler EA. Identification of pathogen genomic variants through an integrated pipeline. Bmc Bioinformatics. 15: 63. PMID 24589256 DOI: 10.1186/1471-2105-15-63 |
0.739 |
|
2013 |
Bopp SE, Rodrigo E, González-Páez GE, Frazer M, Barnes SW, Valim C, Watson J, Walker JR, Schmedt C, Winzeler EA. Identification of the Plasmodium berghei resistance locus 9 linked to survival on chromosome 9. Malaria Journal. 12: 316. PMID 24025732 DOI: 10.1186/1475-2875-12-316 |
0.576 |
|
2013 |
Bopp SE, Manary MJ, Bright AT, Johnston GL, Dharia NV, Luna FL, McCormack S, Plouffe D, McNamara CW, Walker JR, Fidock DA, Denchi EL, Winzeler EA. Mitotic evolution of Plasmodium falciparum shows a stable core genome but recombination in antigen families. Plos Genetics. 9: e1003293. PMID 23408914 DOI: 10.1371/Journal.Pgen.1003293 |
0.809 |
|
2012 |
Nicolaou KC, Lu M, Totokotsopoulos S, Heretsch P, Giguère D, Sun YP, Sarlah D, Nguyen TH, Wolf IC, Smee DF, Day CW, Bopp S, Winzeler EA. Synthesis and biological evaluation of epidithio-, epitetrathio-, and bis-(methylthio)diketopiperazines: synthetic methodology, enantioselective total synthesis of epicoccin G, 8,8'-epi-ent-rostratin B, gliotoxin, gliotoxin G, emethallicin E, and haematocin and discovery of new antiviral and antimalarial agents. Journal of the American Chemical Society. 134: 17320-32. PMID 22978674 DOI: 10.1021/Ja308429F |
0.523 |
|
2011 |
Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, et al. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science (New York, N.Y.). 334: 1372-7. PMID 22096101 DOI: 10.1126/Science.1211936 |
0.775 |
|
2011 |
Nam TG, McNamara CW, Bopp S, Dharia NV, Meister S, Bonamy GM, Plouffe DM, Kato N, McCormack S, Bursulaya B, Ke H, Vaidya AB, Schultz PG, Winzeler EA. A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor. Acs Chemical Biology. 6: 1214-22. PMID 21866942 DOI: 10.1021/Cb200105D |
0.799 |
|
2011 |
Istvan ES, Dharia NV, Bopp SE, Gluzman I, Winzeler EA, Goldberg DE. Validation of isoleucine utilization targets in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America. 108: 1627-32. PMID 21205898 DOI: 10.1073/Pnas.1011560108 |
0.813 |
|
2010 |
Dharia NV, Plouffe D, Bopp SE, González-Páez GE, Lucas C, Salas C, Soberon V, Bursulaya B, Kochel TJ, Bacon DJ, Winzeler EA. Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites. Genome Research. 20: 1534-44. PMID 20829224 DOI: 10.1101/Gr.105163.110 |
0.79 |
|
2010 |
Bopp SE, Ramachandran V, Henson K, Luzader A, Lindstrom M, Spooner M, Steffy BM, Suzuki O, Janse C, Waters AP, Zhou Y, Wiltshire T, Winzeler EA. Genome wide analysis of inbred mouse lines identifies a locus containing Ppar-gamma as contributing to enhanced malaria survival. Plos One. 5: e10903. PMID 20531941 DOI: 10.1371/Journal.Pone.0010903 |
0.621 |
|
2009 |
Dharia NV, Sidhu AB, Cassera MB, Westenberger SJ, Bopp SE, Eastman RT, Plouffe D, Batalov S, Park DJ, Volkman SK, Wirth DF, Zhou Y, Fidock DA, Winzeler EA. Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biology. 10: R21. PMID 19216790 DOI: 10.1186/Gb-2009-10-2-R21 |
0.788 |
|
2008 |
Wentzinger L, Bopp S, Tenor H, Klar J, Brun R, Beck HP, Seebeck T. Cyclic nucleotide-specific phosphodiesterases of Plasmodium falciparum: PfPDEalpha, a non-essential cGMP-specific PDE that is an integral membrane protein. International Journal For Parasitology. 38: 1625-37. PMID 18590734 DOI: 10.1016/J.Ijpara.2008.05.016 |
0.685 |
|
2003 |
Voss TS, Kaestli M, Vogel D, Bopp S, Beck HP. Identification of nuclear proteins that interact differentially with Plasmodium falciparum var gene promoters. Molecular Microbiology. 48: 1593-607. PMID 12791141 DOI: 10.1046/J.1365-2958.2003.03528.X |
0.609 |
|
Show low-probability matches. |